Related Experiment Video
Updated: Jun 2, 2025
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
Intra-Articular Administration of Ganglioside Sugars Protects Cartilage from Progressive Degeneration in an
Masanari Hamasaki1, Tomohiro Onodera1, Junichi Furukawa2,3
1Department of Orthopedic Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Abstract:
ObjectiveOsteoarthritis (OA) is a degenerative joint disease that has no cure, and current therapies are intended to minimize pain. There is, therefore, a need for effective pharmacologic agents that reverse or slow the progression of joint damage. We report herein on an investigation of the effects of intra-articular injections of ganglioside sugars on the progression of OA in an experimental rabbit model.DesignKnee OA was induced Japanese in White rabbits by anterior cruciate ligament transection (ACLT). Ganglioside sugars at concentrations of 0.1, 0.3, and 0.9 mg/ml were then intra-articularly injected as a possible treatment for OA. Controls received intra-articular injections of saline. Knees were assessed macroscopically, histologically, and mechanically at 13 weeks after ACLT induction.ResultsMacroscopically, knees of the groups that received ganglioside sugars at concentrations of 0.3 and 0.9 mg/ml exhibited milder cartilage degradation compared to the controls. Consistent with these results, histological scores for these knees were significantly higher than the corresponding values for the control knees. Lectin histochemistry staining revealed that the treatment with ganglioside sugars at concentrations of 0.3 and 0.9 mg/ml was associated with a remarkable increase in the levels of GalNAc-positive chondrocytes in cartilage. Coefficient of friction testing also demonstrated that cartilages treated with ganglioside sugars had a lower coefficient of frictions than the values for the control group.ConclusionsIntra-articular injections of ganglioside sugars prevented cartilage degeneration in an OA-instability model. These results highlight the promising therapeutic potential for using ganglioside sugars in the treatment of progressive OA.
Insights
Intra-articular injections of ganglioside sugars reduced cartilage damage and improved joint function in a rabbit osteoarthritis model. This suggests ganglioside sugars may be a promising treatment for osteoarthritis progression.
Area of Science:
- Biomedical research
- Orthopedics
- Pharmacology
Background:
- Osteoarthritis (OA) is a degenerative joint disease with no cure, necessitating treatments to slow or reverse joint damage.
- Current OA therapies primarily focus on pain management, highlighting the need for disease-modifying agents.
Purpose of the Study:
- To investigate the therapeutic potential of intra-articular ganglioside sugar injections in an experimental rabbit model of osteoarthritis.
- To evaluate the effects of ganglioside sugars on cartilage degeneration and joint mechanics.
Main Methods:
- Knee osteoarthritis was induced in rabbits via anterior cruciate ligament transection (ACLT).
- Intra-articular injections of ganglioside sugars (0.1, 0.3, 0.9 mg/ml) or saline were administered.
- Knees were assessed macroscopically, histologically, and mechanically 13 weeks post-ACLT.
Main Results:
- Ganglioside sugar injections at 0.3 and 0.9 mg/ml significantly reduced cartilage degradation compared to controls.
- Histological scores and GalNAc-positive chondrocyte levels were notably higher in treated groups.
- Treated cartilage exhibited a lower coefficient of friction, indicating improved mechanical properties.
Conclusions:
- Intra-articular ganglioside sugars demonstrated a protective effect against cartilage degeneration in an OA instability model.
- These findings suggest ganglioside sugars hold therapeutic promise for managing progressive osteoarthritis.
